Seguir
Eduardo M Castaño
Título
Citado por
Citado por
Año
β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy
C Soto, EM Sigurdsson, L Morelli, R Asok Kumar, EM Castaño, ...
Nature medicine 4 (7), 822-826, 1998
11201998
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro
T Wisniewski, EM Castano, A Golabek, T Vogel, B Frangione
The American journal of pathology 145 (5), 1030, 1994
6281994
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
AE Roher, CL Esh, TA Kokjohn, EM Castaño, GD Van Vickle, WM Kalback, ...
Alzheimer's & Dementia 5 (1), 18-29, 2009
4662009
The α-Helical to β-Strand Transition in the Amino-terminal Fragment of the Amyloid β-Peptide Modulates Amyloid Formation∗
C Soto, EM Castano, B Frangione, NC Inestrosa
Journal of Biological Chemistry 270 (7), 3063-3067, 1995
4291995
Differences between vascular and plaque core amyloid in Alzheimer's disease
F Prelli, E Castano, GG Glenner, B Frangione
Journal of neurochemistry 51 (2), 648-651, 1988
4171988
Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.
SG Van Duinen, EM Castano, F Prelli, GT Bots, W Luyendijk, B Frangione
Proceedings of the National Academy of Sciences 84 (16), 5991-5994, 1987
3941987
Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E
EM Castano, F Prelli, T Wisniewski, A Golabek, RA Kumar, C Soto, ...
Biochemical Journal 306 (2), 599-604, 1995
3511995
Degradation of soluble amyloid β-peptides 1–40, 1–42, and the Dutch variant 1–40Q by insulin degrading enzyme from Alzheimer disease and control brains
A Pérez, L Morelli, JC Cresto, EM Castaño
Neurochemical research 25, 247-255, 2000
3202000
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
F Coria, E Castano, F Prelli, M Larrondo-Lillo, S Van Duinen, ...
Laboratory investigation; a journal of technical methods and pathology 58 (4 …, 1988
3101988
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein
EM Castaño, J Ghiso, F Prelli, PD Gorevic, A Migheli, B Frangione
Biochemical and biophysical research communications 141 (2), 782-789, 1986
2991986
Defective ubiquitination of cerebral proteins in Alzheimer's disease
M López Salon, L Morelli, EM Castano, EF Soto, JM Pasquini
Journal of neuroscience research 62 (2), 302-310, 2000
2692000
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
2542021
Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects
EM Castaño, AE Roher, CL Esh, TA Kokjohn, T Beach
Neurological research 28 (2), 155-163, 2006
2452006
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis
RL Patton, WM Kalback, CL Esh, TA Kokjohn, GD Van Vickle, DC Luehrs, ...
The American journal of pathology 169 (3), 1048-1063, 2006
2262006
Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease
W Kalback, C Esh, EM Castaño, A Rahman, T Kokjohn, DC Luehrs, L Sue, ...
Neurological research 26 (5), 525-539, 2004
2122004
Human amyloidosis Alzheimer's disease and related disorders.
EM Castano
Lab Invest 58, 122-132, 1988
2091988
Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic Xray diffraction pattern
PD Gorevic, EM Castano, R Sarma, B Frangione
Biochemical and Biophysical Research Communications 147 (2), 854-862, 1987
2031987
Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
C Soto, EM Castaño, RA Kumar, RC Beavis, B Frangione
Neuroscience letters 200 (2), 105-108, 1995
1841995
Insulin-degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid-β degrading protease
A Bulloj, MC Leal, H Xu, EM Castaño, L Morelli
Journal of Alzheimer's Disease 19 (1), 79-95, 2010
1682010
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein
F Coria, EM Castano, B Frangione
The American journal of pathology 129 (3), 422, 1987
1681987
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20